Jun 15, 2026 12:00PM
Jun 9, 2026 04:30PM
May 13, 2026 02:38AM
Mar 2, 2026 02:00AM
Feb 10, 2026 03:15AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:00AM Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
Dec 6, 2025 09:30AM
Nov 7, 2025 11:00AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM
Jul 21, 2025 08:00AM
Jul 14, 2025 03:00AM Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
Jun 30, 2025 08:00AM
Jun 3, 2025 10:13AM
Jun 3, 2025 10:12AM
Jun 1, 2025 08:00AM
May 14, 2025 05:03PM
May 5, 2025 08:00AM
Mar 3, 2025 06:45AM Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Dec 3, 2024 07:00AM
Nov 7, 2024 07:00AM
Sep 24, 2024 03:00AM
Sep 19, 2024 08:00AM
Aug 7, 2024 06:45AM
Aug 6, 2024 04:01PM
Jun 22, 2024 10:30PM Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
Jun 21, 2024 04:00PM
Jun 18, 2024 08:00AM
Jun 14, 2024 08:00AM
Jun 3, 2024 06:45AM
Jun 1, 2024 08:00AM
May 31, 2024 09:57AM
May 31, 2024 09:57AM Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
May 9, 2024 02:07AM
Apr 26, 2024 08:30AM
Apr 26, 2024 08:30AM
Apr 23, 2024 07:00AM
Apr 18, 2024 07:08PM
Apr 18, 2024 07:00PM
Mar 26, 2024 08:00AM Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Mar 19, 2024 12:20PM

325,238 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All